I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
The bit I cannot resolve on my own is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
Practical detail welcome, however dull — the duller the better.
This one has a reasonably settled answer, so here it is. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.
RetaRick_CA said:It helps to say which part of this you are uncertain about.
Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultsroxy_nash said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
This is my experience too, for whatever a second data point is worth. Nothing to add that would improve it.
Clinical perspective, offered as context rather than as advice. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.